Intellipharmaceutics International Inc. Stock
Stocks
IPCIQ
CA4581733090
Pharmaceuticals
OTC Markets Traded|
Market Closed -
OTC Markets
23:42:19 03/06/2024 +04
|
5-day change | 1st Jan Change | ||
| 0.1000 USD | +66.67% |
|
+9,999,900.00% | +9,999,900.00% |
| 1 week | +9,999,900.00% | ||
| Current month | +9,999,900.00% |
| Market Cap | 1.41M 1.21M 1.14M 1.04M 1.95M 134M 1.96M 13.48M 5.26M 67.85M 5.28M 5.17M 225M | P/E 2021 |
-0.69x | P/E 2022 | -0.82x |
|---|---|---|---|---|---|
| Enterprise Value | 3.65M 3.14M 2.95M 2.69M 5.07M 349M 5.09M 34.97M 13.65M 176M 13.7M 13.4M 584M | EV / Sales 2021 |
-
| EV / Sales 2022 | 70.4x |
| Free-Float |
98.24% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +66.67% | ||
| 1 week | +9,999,900.00% | ||
| Current month | +9,999,900.00% | ||
| 1 month | +9,999,900.00% | ||
| 3 months | +9,999,900.00% | ||
| 6 months | +9,999,900.00% | ||
| Current year | +9,999,900.00% |
| Current year | 0 |  | 0.1 |
| 1 year | 0 | | 0.1 |
| 3 years | 0 | | 0.15 |
| 5 years | 0 | | 0.3 |
| 10 years | 0 | | 33.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amina Odidi
DFI | Director of Finance/CFO | - | - |
| Comptroller/Controller/Auditor | - | 01/04/2007 | |
| Corporate Officer/Principal | - | 01/02/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Amina Odidi
BRD | Director/Board Member | - | 01/09/2004 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +66.67% | +9,999,900.00% | +9,999,900.00% | +42.86% | 33 | |
| -0.13% | -6.44% | +60.34% | +112.06% | 1,047B | |
| +0.85% | -0.81% | +51.29% | +63.13% | 646B | |
| -1.03% | -3.58% | +21.43% | +73.10% | 451B | |
| -1.46% | -4.50% | +37.80% | +37.41% | 355B | |
| -0.72% | -2.89% | +22.32% | +36.62% | 291B | |
| -1.19% | -2.21% | +1.53% | +10.79% | 252B | |
| -1.05% | -1.57% | +50.30% | +66.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.36% | 203B | |
| -2.14% | -0.30% | +28.95% | +86.27% | 181B | |
| Average | +5.99% | -2.41% | +1,000,015.63% | +47.44% | 365.93B | |
| Weighted average by Cap. | -0.46% | -3.46% | +38.17% | +65.00% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | 65.73K 56.64K 53.1K 48.48K 91.32K 6.28M 91.61K 630K 246K 3.17M 247K 241K 10.51M |
| Net income | -5.15M -4.43M -4.16M -3.79M -7.15M -492M -7.17M -49.32M -19.24M -248M -19.32M -18.9M -823M | -2.89M -2.49M -2.34M -2.13M -4.02M -276M -4.03M -27.72M -10.82M -140M -10.86M -10.62M -463M |
| Net Debt | 1.15M 987K 925K 845K 1.59M 109M 1.6M 10.98M 4.28M 55.26M 4.3M 4.21M 183M | 2.24M 1.93M 1.81M 1.65M 3.12M 214M 3.13M 21.49M 8.39M 108M 8.42M 8.24M 359M |
Employees
11
Sector
Pharmaceuticals
- Stock Market
- Stocks
- IPCIQ Stock
Select your edition
All financial news and data tailored to specific country editions
